A new study by EPA Victoria scientists has shown that chemicals used in pharmaceuticals and personal care products (PPCPs) are increasingly finding their way into the environment.
The study – Pharmaceuticals in Biota: The impact of wastewater treatment plant effluents on fish in Australia looked for 46 specific PPCPs including chemicals used in anti-depressants, pain control, blood pressure products and anti-bacterial agents used in soap.
Researchers took water and fish samples at 15 locations upstream and downstream of wastewater treatment plants (WWTPs) around Victoria.
While the study identifies an increasing presence of PPCPs in the environment, it also found that consumption of the affected fish poses a low risk to human health.
According to Minna Saaristo, the study’s lead scientist, Principal Scientist Ecological Risk and Emerging Contaminants, 12 PPCPs were detected in surface waters and five PPCPs in fish living upstream and downstream from wastewater treatment plants in Victoria.
The most frequently detected PPCPs in water were venlafaxine, metoprolol, carbamazepine, propranolol, sulfamethoxazole and sertraline, which are medications used to treat a range of health issues from depression to blood pressure and heart problems, control seizures and treat pain, and present in consumer products as antibacterial agents.
Out of the 46 PPCPs analysed in fish, five compounds (caffeine, carbamazepine, sertraline, triclosan and venlafaxine) were detected.
These compounds are also associated with medications used to treat depression, control pain and incorporated into consumer products as antibacterial agents.
Researchers said many of the PPCPs in the environment have likely come from domestic sources through the sewer system to the wastewater treatment plant.
“Based on our human health risk calculations, the levels of PPCPs detected in fish samples were not at levels that would cause health issues to humans, but it shows the growing need to look at source control and how wastewater treatment plants manage PPCPs into the future,” said Saaristo.
“We have to be mindful of potential mixture effect of the chemical cocktail that is being created in the environment.”
Saaristo said evidence shows that levels of antidepressants detected in the environment today could alter fish behaviour.
“Such as courtship dances or fear responses, and might have a detrimental effect on population levels,” she said.
“Information gathered from our recent report will assist EPA to provide advice to stakeholders on how to improve their treatment processes in the future.”
Further research is underway. EPA, water corporations and research institutions are working together to understand the effects of emerging contaminants, such as PPCPs and to develop solutions.
For more information, Pharmaceuticals in biota: The impact of wastewater treatment plant effluents on fish in Australia – ScienceDirect
Related stories:
EPA tests water for pollutants